LIBRA-seq for Coronavirus
Joseph (Stockton, CA) on 09/25/2021:
Vanderbilt university medical center has led to the discovery of an Ultra-potent monoclonal antibody against multiple variants of SARS-coV-2, the virus responsible for COVID-19, including the Delta Variant. The technology, called Libra-seq
